Close

Eli Lilly & Co. (LLY) Presents Data on two Immuno-Oncology Studies with Merck (MRK)

June 6, 2016 6:14 AM EDT Send to a Friend
Eli Lilly and Company (NYSE: LLY) announced that clinical study data from two of its ongoing immuno-oncology clinical collaborations with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login